Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-21

Clinical Trial Update: Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization [NA]

View source ↗

Summary

Clinical trial update assessing the safety and effectiveness of Tivoli and Firebird2 drug-eluting stents for coronary revascularization

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Firebird2 DES
  • Tivoli DES

Snippet

Sponsor: Essen Technology (Beijing) Co., Ltd. | Conditions: Ischemic Heart Disease, Myocardial Ischemia | NA | Status: UNKNOWN